Barrington Research: Maintaining the Surmodics (SRDX.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $71.00 to $71.00.
Barrington Research：维持Surmodics(SRDX.US)评级，由优于大市调整至优于大市评级, 目标价由71.00美元调整至71.00美元。
Barrington Research: Maintaining the Surmodics (SRDX.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $71.00 to $71.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.